Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 11 , ISSUE 2 ( March-April, 2019 ) > List of Articles

Original Article

Low-dose Intravenous Magnesium Sulfate: Efficacy and Safety in Eclamptic Indian Women

Mohita Agarwal, Saroj Singh, Almas Ara

Keywords : Eclampsia, Low-dose magnesium sulfate, Pritchard's regimen

Citation Information : Agarwal M, Singh S, Ara A. Low-dose Intravenous Magnesium Sulfate: Efficacy and Safety in Eclamptic Indian Women. J South Asian Feder Obs Gynae 2019; 11 (2):85-89.

DOI: 10.5005/jp-journals-10006-1661

License: CC BY-NC 4.0

Published Online: 01-06-2019

Copyright Statement:  Copyright © 2019; The Author(s).


Objective: The aim of our study was to evaluate the efficacy and safety of low dose intravenous magnesium sulfate against the conventional Pritchard's regimen in cases of eclampsia. Materials and methods: A total of 60 eclamptic cases attending the labor room were randomly allocated to receive low dose intravenous magnesium sulfate, i.e., 4 g intravenous bolus dose followed by a 0.8 g per hour maintenance dose to be continued up to 24 hours after delivery or the last fit, whichever is later, or conventional Pritchard's regimen. The two groups were compared for efficacy and safety. Results: Low-dose regimen was found to have a statistically significant lower incidence of side-effects and complications. Failure of therapy was seen in more number of cases with low dose because of the lower serum magnesium levels. Conclusion: Low-dose regimen is a good option for lean Indian women especially at the peripheral centers where intensive serum magnesium level monitoring is not practically feasible because of reduced risk of toxicity.

  1. Chang CC, Incaudo GA, et al. Diseases of the Sinuses: A Comprehensive Textbook of Diagnosis and Treatment. Springer; 2014. p. 601.
  2. Sundararaju V, Ramaratnam S, et al. Topiramate versus carbamazepine monotherapy for partial onset seizures or generalized onset tonic-clonic seizures with or without other generalized seizure types. Cochrane Database Syst Rev 2010;84:210–217.
  3. Adekanle DA, Loto OM. Comparison of Intramuscular Magnesium Sulphate with Low Dose Intravenous Regimen in the Management of Eclampsia in Low Resource Setting: A Randomised Study. Obstet Gynecol 2014;04(09). DOI: 10.4172/2161-0932.1000249.
  4. Sardesai S. Chapter-21 Eclampsia Management-What is New? Pediatric Dermatology Ward Rounds 2007:263–278.
  5. Say L, Barreix M, et al. Maternal morbidity measurement tool pilot: study protocol. Reprod Health 2016;13(1):69. DOI: 10.1186/s12978-016-0164-6.
  6. Begum R, Begum A, et al. A low dose (‘Dhaka’) magnesium sulphate regime for eclampsia. Clinical findings and serum magnesium levels. Acta Obstet Gynecol Scand 2001;80(11):998–1002. DOI: 10.1080/obs.80.11.998.1002.
  7. Singh A, Verma AK, et al. Serum magnesium levels in cases with preeclampsia and eclampsia with different regimens of magnesium sulphate. Global J Med Public Health 2013;2:1–5.
  8. Das M, Chaudhuri PR, et al. Assessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen. Indian J Pharmacol 2015;47:502–508. DOI: 10.4103/0253-7613.165183.
  9. Malapaka SVN, Ballal PK. Low-dose magnesium sulphate versus Pritchard regimen for the treatment of eclampsia imminent eclampsia. Int J Gynecol Obstet 2011;115:70–72.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.